Smartleaf Asset Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$219K Hold
8,399
0.01% 792
2026
Q1
$217K Buy
8,399
+495
+6% +$14.8K 0.01% 758
2025
Q4
$249K Buy
7,904
+706
+10% +$22K 0.01% 712
2025
Q3
$211K Buy
7,198
+1,190
+20% +$29K 0.01% 709
2025
Q2
$123K Buy
6,008
+236
+4% +$4.84K 0.01% 785
2025
Q1
$115K Buy
5,772
+1,236
+27% +$25.9K 0.01% 775
2024
Q4
$94.2K Sell
4,536
-2,155
-32% -$47.3K 0.01% 863
2024
Q3
$163K Buy
6,691
+4,368
+188% +$117K 0.02% 562
2024
Q2
$59.4K Buy
2,323
+123
+6% +$3.49K 0.01% 696
2024
Q1
$67.4K Buy
2,200
+55
+3% +$1.62K 0.01% 610
2023
Q4
$68.5K Buy
+2,145
New +$67.3K 0.02% 488

Other funds holding GMAB

Smartleaf Asset Management's GMAB Position: Q2 2026 in Review

Smartleaf Asset Management held its Genmab (GMAB) position steady in Q2 2026 at 8,399 shares worth $219K. The position accounts for 0.01% of the portfolio, ranked #792.

Smartleaf Asset Management first reported a position in GMAB in Q4 2023 and has held it in 11 quarters since. The position peaked at $249K in Q4 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Smartleaf Asset Management held 8,399 shares of Genmab worth $219K as of Q2 2026.
  • Smartleaf Asset Management left its Genmab share count unchanged in Q2 2026.
  • Genmab made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #792 holding.
  • Smartleaf Asset Management first reported a position in Genmab in Q4 2023 and has held it in 11 quarters since.
  • Smartleaf Asset Management's Genmab position peaked at $249K in Q4 2025.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.